GO:0002415 immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor: Mucosal Immunity Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002415 describes the pIgR-dependent transport of polymeric IgA and IgM from the basolateral to the apical surface of epithelial cells, releasing secretory component (SC)-bound immunoglobulin into mucosal secretions.
• The polymeric immunoglobulin receptor (PIGR) is the central receptor that binds dimeric IgA and pentameric IgM and carries them across epithelial cells by transcytosis.
• At the apical surface, pIgR is cleaved and its extracellular domain remains bound to the immunoglobulin as secretory component (SC), which protects antibodies in mucosal environments.
• This pathway is essential for mucosal immune defense and is exploited by pathogens such as Streptococcus pneumoniae to cross epithelial barriers.
• pIgR expression is regulated by cytokines including interferon-gamma and by cholinergic signals in epithelial cells.
• pIgR and this transcytosis process are implicated in cancer progression and represent potential therapeutic targets.
Description
GO:0002415, immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor, is a biological process that transports polymeric IgA and polymeric IgM across epithelial cells. This process is fundamental to mucosal immunity, allowing antibodies produced in the lamina propria to reach mucosal surfaces where they neutralize pathogens. The polymeric immunoglobulin receptor (pIgR) binds these immunoglobulins at the basolateral surface and carries them through the cell to the apical surface. At the apical surface, the pIgR is cleaved, and its extracellular portion, known as secretory component (SC), remains bound to the immunoglobulin, forming secretory IgA or secretory IgM. This mechanism is conserved across species and is critical for host defense at mucosal barriers. Researchers study GO:0002415 to understand mucosal immunity, pathogen evasion, and epithelial cell biology. The process also has implications for cancer biology, as pIgR expression and function are altered in various carcinomas. Experimental models, including epithelial cell lines and animal models, have been used to dissect the molecular steps of this pathway.
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor At A Glance
| GO ID | GO:0002415 |
|---|---|
| GO term | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor |
| Ontology | biological_process |
| Synonym | antibody transcytosis mediated by pIgR; immunoglobulin transcytosis mediated by pIgR |
| Major function | Transport of polymeric IgA and IgM across epithelial cells from basolateral to apical surface, releasing secretory component-bound immunoglobulin into mucosal secretions. |
| Cellular location | Epithelial cells, particularly mucosal epithelia; involves basolateral and apical surfaces. |
| Key receptor | Polymeric immunoglobulin receptor (pIgR), encoded by the PIGR gene. |
| Cargo | Polymeric IgA (dimeric IgA) and polymeric IgM (pentameric IgM); also IgA immune complexes. |
| Secretory component | Cleaved extracellular domain of pIgR that remains bound to immunoglobulin at the apical surface. |
What Is GO:0002415?
GO:0002415 is defined as the process of transporting polymeric IgA and polymeric IgM immunoglobulin, via transcytosis mediated by the polymeric immunoglobulin receptor (pIgR), from the basolateral surface to the apical surface of an epithelial cell. At the apical surface, the immunoglobulin-binding portion of the pIgR is cleaved and remains bound to the transported immunoglobulin as secretory component (SC). The same process is used for the transport and excretion of IgA immune complexes to the luminal surface of the mucosa.
Why Is immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor Important in Cell Biology?
GO:0002415 is essential for mucosal immunity because it enables the delivery of polymeric IgA and IgM to mucosal surfaces, where they provide first-line defense against pathogens. This process also contributes to the excretion of IgA immune complexes, helping to clear antigens from the body. Dysregulation of pIgR-mediated transcytosis is associated with increased susceptibility to infections and has been linked to cancer progression. Understanding this pathway is therefore critical for developing vaccines and therapies that target mucosal immunity.
• Provides mucosal protection by transporting neutralizing antibodies to epithelial surfaces.
• Facilitates immune exclusion of pathogens and toxins at mucosal barriers.
• Enables excretion of IgA immune complexes, aiding in antigen clearance.
• Exploited by pathogens such as Streptococcus pneumoniae to cross epithelial barriers.
• pIgR expression is regulated by cytokines and neurotransmitters, linking immunity and neuroimmune interactions.
• Altered pIgR function is implicated in cancer progression and metastasis.
• Secretory component (SC) protects immunoglobulins from proteolytic degradation in mucosal secretions.
• Defects in this pathway can lead to increased susceptibility to mucosal infections.
• Serves as a model for studying transcytosis and polarized epithelial cell trafficking.
• Potential target for therapeutic antibodies and vaccine design.
What Happens During immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor?
Binding of polymeric IgA and IgM to pIgR at the basolateral surface
In simple terms: Antibodies produced in the tissue beneath the epithelium attach to a receptor on the bottom side of epithelial cells.
The polymeric immunoglobulin receptor (pIgR) is expressed on the basolateral surface of epithelial cells, where it binds polymeric IgA (dimeric IgA) and polymeric IgM (pentameric IgM) with high affinity. This binding is the first step in the transcytosis process and is essential for the selective transport of these immunoglobulins. The interaction involves the extracellular domain of pIgR, which contains five immunoglobulin-like domains. Studies in epithelial cell lines have shown that this binding is saturable and specific for polymeric immunoglobulins.
Endocytosis and transcytosis across the epithelial cell
In simple terms: The receptor-antibody complex is taken into the cell and carried across to the other side.
After binding, the pIgR-immunoglobulin complex is internalized via clathrin-coated pits and transported through the endosomal system. The complex moves across the cell in a process called transcytosis, which involves sorting in endosomes and transport along microtubules. This step is regulated by various signaling molecules and can be enhanced by factors such as biparatopic VHH antibodies. The transcytotic pathway delivers the complex to the apical surface.
Cleavage of pIgR and release of secretory component-bound immunoglobulin
In simple terms: At the top surface, the receptor is cut, and a piece of it stays attached to the antibody, forming a protective shield.
At the apical surface, the extracellular domain of pIgR is cleaved by proteases, releasing the immunoglobulin bound to a fragment of pIgR known as secretory component (SC). This cleavage is a key step that allows the immunoglobulin to be released into mucosal secretions while remaining protected by SC. The SC-immunoglobulin complex, known as secretory IgA or secretory IgM, is then free to function in mucosal defense. The cleavage is mediated by unidentified proteases, but it is a conserved feature of this pathway.
Transport of IgA immune complexes and excretion
In simple terms: The same receptor can also carry antibody-antigen complexes out of the body through mucosal surfaces.
In addition to transporting free polymeric immunoglobulins, pIgR can mediate the transcytosis of IgA immune complexes, facilitating their excretion to the luminal surface. This process helps clear antigens from the body and is important for immune complex clearance. The mechanism is similar to that of free immunoglobulin transport, involving binding at the basolateral surface and release at the apical surface. This function contributes to mucosal homeostasis and defense.
Key Genes Involved in GO:0002415 immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor
The following genes and proteins are key players in GO:0002415, including the receptor itself, immunoglobulin components, and regulatory factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIGR | Encodes the polymeric immunoglobulin receptor that binds and transcytoses IgA and IgM | Central to the pathway; knockout and overexpression models used to study mucosal immunity |
| IGHA1 | Encodes IgA heavy chain constant region; forms polymeric IgA | Cargo for pIgR; mutations affect IgA production and transcytosis |
| IGHM | Encodes IgM heavy chain constant region; forms polymeric IgM | Cargo for pIgR; important for early mucosal immune responses |
| JCHAIN | Encodes joining chain that links IgA and IgM monomers into polymers | Essential for polymeric immunoglobulin formation and pIgR binding |
| IFNG | Encodes interferon-gamma, a cytokine that upregulates PIGR expression | Regulates pIgR levels in epithelial cells; studied in infection and inflammation |
| IL4 | Interleukin-4, cytokine that can modulate pIgR expression | May influence pIgR-mediated transcytosis in allergic and immune responses |
| TNF | Tumor necrosis factor, pro-inflammatory cytokine | Can affect pIgR expression and epithelial barrier function |
| CHRM3 | Muscarinic acetylcholine receptor M3 | Cholinergic regulation of pIgR expression in Caco-2 cells |
| CHRNA7 | Nicotinic acetylcholine receptor alpha-7 | Potential role in cholinergic modulation of pIgR |
| ST6GAL1 | Sialyltransferase that modifies pIgR glycosylation | Glycosylation affects pIgR function and stability |
| FUT2 | Fucosyltransferase 2, involved in epithelial glycosylation | May influence pIgR-mediated transcytosis and mucosal immunity |
| RAB11A | Small GTPase involved in vesicular transport | Regulates transcytosis of pIgR-IgA complexes |
| RAB25 | Small GTPase implicated in apical recycling | May modulate pIgR transcytosis |
| CLTC | Clathrin heavy chain, involved in endocytosis | Required for internalization of pIgR-immunoglobulin complexes |
| AP1B1 | Adaptor protein complex 1, beta-1 subunit | Sorts pIgR in endosomes during transcytosis |
| MICALL2 | MICAL-like 2, involved in vesicle trafficking | Potential regulator of pIgR transcytosis |
| MYO5B | Myosin Vb, motor protein for vesicle transport | Facilitates apical transport of pIgR |
| PRKCI | Protein kinase C iota, involved in polarity | Regulates epithelial polarity and transcytosis |
How Is immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor Regulated?
The expression and function of pIgR, and thus GO:0002415, are regulated at multiple levels. Interferon-gamma (IFN-gamma) upregulates PIGR mRNA and protein in epithelial cells, enhancing transcytosis. Cholinergic signaling through muscarinic receptors has been shown to modulate pIgR expression in Caco-2 cells. Additionally, cytokines such as IL-4 and TNF can influence pIgR expression, although the exact mechanisms vary by cell type. Post-translational modifications, including glycosylation, affect pIgR stability and function. The transcytotic pathway itself is regulated by small GTPases and adaptor proteins that control vesicle trafficking.
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIGR | Mucosal infections, cancer progression | PIGR knockout mice, epithelial cell lines (e.g., Caco-2) |
| IGHA1 | IgA deficiency, mucosal infections | IgA knockout mice, patient-derived organoids |
| IGHM | IgM deficiency, susceptibility to infections | IgM knockout mice, B cell cultures |
| JCHAIN | Defective polymeric immunoglobulin assembly | Jchain knockout mice, recombinant expression systems |
| IFNG | Inflammatory diseases, infection susceptibility | IFN-gamma knockout mice, cytokine stimulation assays |
Mucosal infections and pathogen evasion
GO:0002415 is critical for mucosal defense, and its dysfunction can lead to increased susceptibility to infections. Some pathogens, such as Streptococcus pneumoniae, exploit pIgR to translocate across epithelial barriers, contributing to invasive disease. Understanding this process is important for developing strategies to prevent pathogen dissemination.
Cancer progression
pIgR expression is altered in various cancers, and its role in transcytosis may affect tumor progression and immune surveillance. In some carcinomas, loss of pIgR is associated with poor prognosis, while in others, overexpression may promote tumor growth. Targeting pIgR-mediated pathways is being explored as a therapeutic strategy.
Autoimmune and inflammatory diseases
Defects in IgA transcytosis can lead to altered mucosal immunity and have been implicated in inflammatory bowel diseases and autoimmune conditions. The excretion of IgA immune complexes via pIgR is important for clearing antigens and may influence disease pathogenesis.
From immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of PIGR in mucosal IgA transport? | PIGR knockout mouse model |
| How do point mutations in PIGR affect ligand binding? | CRISPR point-mutation knock-in in epithelial cell lines |
| Can we visualize pIgR transcytosis in real time? | Tagged knock-in of PIGR with fluorescent protein in Caco-2 cells |
| What is the effect of PIGR overexpression on pathogen translocation? | PIGR overexpression in nasopharyngeal epithelial cells |
| How does IFN-gamma regulate PIGR expression? | IFN-gamma treatment of mammary epithelial cells with PIGR reporter |
| What genes are essential for pIgR-mediated transcytosis? | Genome-wide CRISPR knockout library screening in epithelial cells |
How to Study the immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | PIGR mRNA expression and transcript variants | Studying regulation by cytokines or pathogens |
| Proteomics | pIgR protein interactions and modifications | Identifying components of the transcytosis machinery |
| Confocal microscopy | Localization and trafficking of pIgR and cargo | Visualizing transcytosis in polarized cells |
| Transwell assay | Rate of IgA/IgM transport across epithelial monolayers | Functional assessment of transcytosis |
| CRISPR knockout screening | Genes required for pIgR-mediated transcytosis | Identifying novel regulators |
| Flow cytometry | Surface expression of pIgR | Quantifying receptor levels on epithelial cells |
| Western blot | pIgR and secretory component protein levels | Validating expression changes |
| ELISA | Secreted IgA/IgM in apical medium | Measuring transcytosis output |
Transcriptomic analysis of pIgR and related genes
RNA-seq can be used to measure PIGR mRNA levels and identify splicing variants or mutations in epithelial cells under different conditions. This approach helps quantify changes in expression in response to cytokines or pathogens.
Proteomic and glycomic profiling of pIgR
Mass spectrometry-based proteomics can identify pIgR interacting proteins and post-translational modifications, such as glycosylation, that affect its function. These methods provide insights into the molecular composition of the transcytosis machinery.
Imaging transcytosis in polarized epithelial cells
Confocal microscopy and live-cell imaging of fluorescently tagged pIgR and immunoglobulins allow visualization of the transcytotic pathway from basolateral to apical surfaces. This is useful for studying the dynamics of vesicle trafficking.
Functional assays for transcytosis
In vitro transwell assays using polarized epithelial cells measure the transport of IgA or IgM from the basolateral to apical compartment. These assays can be combined with inhibitors or gene knockouts to dissect the pathway.
How CRISPR Can Be Used to Study GO:0002415 immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor
Knockout
CRISPR knockout of PIGR in epithelial cell lines abolishes IgA and IgM transcytosis, providing a clean model to study the pathway's contribution to mucosal immunity. Knockout of genes encoding cargo immunoglobulins or trafficking machinery can also disrupt transcytosis.
Point Mutation
Introducing point mutations in PIGR that affect ligand binding or cleavage can help dissect the molecular requirements for transcytosis. For example, mutations in the cleavage site can prevent secretory component release.
Knock-in
Knock-in of tagged PIGR (e.g., GFP or HA) allows real-time tracking of the receptor and its cargo in live cells. This approach is valuable for imaging transcytosis and studying trafficking dynamics.
Overexpression
Overexpression of PIGR in epithelial cells can enhance transcytosis and increase secretion of IgA/IgM. This model is useful for studying the effects of increased pIgR levels on pathogen translocation and immune defense.
How EDITGENE Supports immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor Research
Researchers studying immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with its activity. CRISPR-based models provide a robust way to establish causality by precisely manipulating genes in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor research.
Frequently Asked Questions About immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor
What is GO:0002415?
GO:0002415 is the biological process of transporting polymeric IgA and IgM across epithelial cells via the polymeric immunoglobulin receptor (pIgR), releasing them as secretory component-bound immunoglobulins at the apical surface.
What genes are involved in immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor?
Key genes include PIGR (the receptor), IGHA1 and IGHM (immunoglobulin heavy chains), JCHAIN (joining chain), and regulatory genes such as IFNG.
How does pIgR mediate transcytosis?
pIgR binds polymeric IgA and IgM at the basolateral surface, internalizes them, transports them across the cell, and is cleaved at the apical surface, releasing the immunoglobulin bound to secretory component.
What is secretory component (SC)?
Secretory component is the cleaved extracellular domain of pIgR that remains bound to IgA or IgM at the apical surface, protecting the immunoglobulin in mucosal secretions.
Which diseases are associated with defects in this pathway?
Defects in pIgR-mediated transcytosis are associated with increased susceptibility to mucosal infections and have been implicated in cancer progression.
Can pathogens exploit pIgR-mediated transcytosis?
Yes, Streptococcus pneumoniae can use pIgR to translocate across nasopharyngeal epithelial cells, contributing to invasive disease.
How is pIgR expression regulated?
pIgR expression is upregulated by interferon-gamma and modulated by cholinergic signaling and other cytokines.
What experimental models are used to study GO:0002415?
Common models include polarized epithelial cell lines (e.g., Caco-2), PIGR knockout mice, and CRISPR-engineered cells.
What methods measure transcytosis?
Transwell assays, confocal microscopy, and ELISA for secreted immunoglobulins are commonly used.
Why is GO:0002415 important for mucosal immunity?
It delivers protective antibodies to mucosal surfaces and helps clear immune complexes, forming a first line of defense against pathogens.
Conclusion
GO:0002415, immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor, is a fundamental biological process for mucosal immunity. It enables the transport of polymeric IgA and IgM across epithelial barriers, providing protection at mucosal surfaces and facilitating immune complex clearance. Dysregulation of this pathway is linked to infections and cancer, making it a significant area of research. Advances in CRISPR-based models and imaging techniques continue to unravel the molecular details of this process, offering potential therapeutic targets.
References
- 1. Asano M et al.. 2011. Polymeric immunoglobulin receptor.. J Oral Sci 53(2):147-56 PMID: 21712618
- 3. Qian S et al.. 2025. Polymeric immunoglobulin receptor (pIgR) in cancer progression: a critical role and potential therapeutic target.. Apoptosis 30(7-8):1751-1775 PMID: 40415061
- 4. Xu G et al.. 2023. Interferon-γ mediating overexpression of polymeric immunoglobulin receptor in grass carp (Ctenopharyngodon idellus) liver cells.. Dev Comp Immunol 146:104746 PMID: 37257764
- 5. Higuera-Martínez G et al.. 2025. Cholinergic regulation on polymeric immunoglobulin receptor expression in Caco-2 cells.. Acta Pharm 75(3):547-555 PMID: 41190722
- 6. Emmerson CD et al.. 2011. Enhancement of polymeric immunoglobulin receptor transcytosis by biparatopic VHH.. PLoS One 6(10):e26299 PMID: 22022593
- 7. Zhang JR et al.. 2000. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells.. Cell 102(6):827-37 PMID: 11030626
- 8. Rincheval-Arnold A et al.. 2002. Up-regulation of polymeric immunoglobulin receptor mRNA in mammary epithelial cells by IFN-gamma.. Mol Cell Endocrinol 194(1-2):95-105 PMID: 12242032
